Vitiligo Treatment in Nandyala
Vitiligo causes white patches of depigmentation that carry significant emotional and social impact — particularly in South Indian society where skin tone is deeply personal. Dr. Sireesha at Yashvini Skin & Hair Clinic, Nandyala, offers the latest evidence-based treatments to restore pigmentation and improve confidence.
What Is Vitiligo?
Vitiligo is a chronic autoimmune condition in which the immune system attacks and destroys melanocytes — the cells responsible for producing skin pigment (melanin). The result is well-defined, white or depigmented patches that can appear anywhere on the body, but most commonly affect the face, hands, feet, and areas around body orifices. The condition affects approximately 1–2% of the world's population and occurs across all skin types.
Vitiligo can be classified as non-segmental (symmetrical patches on both sides of the body — the most common form) or segmental (patches on one side of the body, following a dermatomal pattern, typically more stable and faster spreading). Understanding the type is crucial for treatment planning. Associated autoimmune conditions — particularly thyroid disease (Hashimoto's thyroiditis, Graves' disease), type 1 diabetes, and alopecia areata — are more common in vitiligo patients and require screening.
In South Indian society, where skin tone carries considerable personal and matrimonial significance, vitiligo can cause profound psychosocial distress — affecting self-esteem, relationships, and career. Early treatment offers the best chance of achieving repigmentation before melanocyte stem cells are permanently lost. Dr. Sireesha takes both the medical and emotional dimensions of vitiligo seriously, and provides compassionate, expert care.
Causes
Symptoms & Types
Non-Segmental Vitiligo (Generalised)
The most common form. Symmetrical white patches that tend to progressively enlarge and may involve large areas over time. Commonly affects hands, wrists, knees, elbows, face, and periorificial areas (around the mouth, eyes, and genitalia). May be associated with thyroid disease.
Segmental Vitiligo
White patches confined to one side of the body, often following a nerve distribution (dermatomal). Tends to spread rapidly during the initial phase, then stabilise. Less associated with autoimmune conditions. Responds particularly well to melanocyte transplantation once stable.
Focal Vitiligo
One or a few isolated white patches in one area, without a segmental distribution. May represent early generalised vitiligo or remain localised.
Universal Vitiligo
Near-complete or complete depigmentation of the body surface. Rare. May warrant consideration of complete depigmentation therapy for cosmetic consistency.
Mucosal Vitiligo
Depigmentation of the lips, oral mucosa, or genital mucosa. More resistant to repigmentation treatments than skin vitiligo.
Acrofacial Vitiligo
Patches around the extremities (fingers, toes) and face. Very common pattern in Indian patients. Fingertip vitiligo (digits) is particularly challenging to repigment.
Treatment Options at Yashvini Clinic
NB-UVB Phototherapy (First-Line for Widespread Vitiligo)
Narrowband UVB (311 nm) phototherapy is the gold-standard treatment for widespread vitiligo. It works by stimulating residual melanocyte stem cells in hair follicles to proliferate and repigment the skin, while also modulating the autoimmune attack. Sessions are conducted 2–3 times per week. A minimum of 48–72 sessions is usually needed for full repigmentation assessment. Best results are seen on the face and trunk; acral areas (hands, feet) respond less well.
Topical Tacrolimus and Calcineurin Inhibitors
Topical tacrolimus (0.1%) and pimecrolimus are non-steroidal agents that suppress the autoimmune attack on melanocytes. Particularly effective for small patches on the face, neck, and genitals where potent steroids are not appropriate. Can be combined with phototherapy for enhanced results. Used twice daily on affected patches.
JAK Inhibitors (Ruxolitinib / Tofacitinib)
A breakthrough in vitiligo treatment. Topical ruxolitinib (1.5% cream) — approved by the FDA for vitiligo — works by blocking JAK-STAT inflammatory signalling that drives melanocyte destruction. Achieves significant facial and body repigmentation in clinical trials. Oral JAK inhibitors (tofacitinib) are also used for extensive vitiligo under careful monitoring. Available at Yashvini Skin & Hair Clinic under Dr. Sireesha's supervision.
Melanocyte Transplantation (Surgical Repigmentation)
For stable vitiligo (no new patches for 1–2 years), surgical options offer excellent results. The mini punch grafting and split-thickness skin grafting techniques, as well as non-cultured epidermal cell suspension transplantation (ReCell), transplant melanocytes from unaffected donor skin to depigmented patches. Best suited for segmental and focal vitiligo. Produces uniform, natural-looking repigmentation.
Topical and Oral Corticosteroids
Topical corticosteroids (mid-to-high potency) are used for localised, active vitiligo to halt progression and stimulate repigmentation. Oral corticosteroids (mini-pulse therapy) may be prescribed for rapidly spreading vitiligo to arrest disease activity. Careful monitoring is essential due to long-term side effect risks.
Camouflage and Psychosocial Support
Dermatological-grade camouflage products provide instant cosmetic improvement and are particularly valuable for visible areas (face, hands). Self-tanning preparations can help blend patches on the body. Dr. Sireesha also addresses the psychosocial impact of vitiligo and can refer for psychological support where needed, recognising the significant distress vitiligo causes in South Indian patients.
What to Expect
Before Treatment
- A thorough clinical examination by Dr. Sireesha to determine vitiligo type, extent (VASI score), activity (stable vs. progressive), and identify any associated autoimmune conditions.
- Wood's lamp examination to clearly delineate patches and assess completeness of depigmentation.
- Baseline blood tests: thyroid function (TSH, T3, T4, thyroid antibodies), fasting blood glucose, complete blood count.
- Photographic documentation of all patches to track treatment response over time.
- Manage expectations: repigmentation is achievable but gradual — early treatment gives the best results.
- Discuss the emotional impact of vitiligo and available psychological support resources.
During Treatment
- Phototherapy sessions attended as scheduled 2–3 times per week; consistency is critical — missing sessions significantly reduces efficacy.
- Topical agents applied to patches as prescribed, morning and evening or as directed.
- Repigmentation begins as small 'perifollicular' dots of pigment within patches — this is a positive sign of treatment working.
- Report any new white patches or rapid spread immediately — treatment adjustment may be needed.
- Eye protection (UV-blocking goggles) worn during all phototherapy sessions.
- Sun protection applied on non-phototherapy days to prevent burns in depigmented skin.
After Treatment
- Repigmented areas should be protected from sun exposure to maintain the new pigmentation.
- Continue maintenance topical therapy (tacrolimus or ruxolitinib) as directed to prevent recurrence.
- Monitor thyroid function and other associated conditions annually.
- New patches may appear despite treatment in active disease — prompt reporting allows timely treatment adjustment.
- Stable repigmented areas from surgical procedures need protection from sun and trauma.
- Long-term follow-up with Dr. Sireesha every 3–6 months is recommended for ongoing monitoring.
Benefits
Aftercare & Home Care
Frequently Asked Questions
తెలుగులో సమాధానాలు
Frequently Asked Questions — in Telugu & English
Seeking Vitiligo Treatment in Nandyala? Start Early for Best Results.
Book a consultation with Dr. Sireesha at Yashvini Skin & Hair Clinic, Nandyala.